. . . . . . . . . . . . . "a(CHEBI:gefitinib) -| p(HGNC:EGFR,pmod(P,Y,1092))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "In the parental cell line, EGFR, ERBB3, ERBB2, and METwere all phosphorylated, and this phosphorylation was either completely or markedly reduced upon gefitinib treatment.The phospho-specific EGFR (pY1068), MET (pY1234/1235), ERK1/2 (pT185/pY187) antibodies were purchased from Invitrogen (Carlsbad, CA)." . . "Selventa" . . . . "2014-07-03T14:33:10.264+02:00"^^ . . .